Skip to content
Recall Observatory FDA recall evidence

Drug product

Optiray 320 (ioversol) Injection 68%, 320 mg/mL Organically Bound Iodine, packaged in 1 - 100 mL Ultraject Prefilled Syringe For Power Injection per carton, RFID Technology, Rx Only, Manufactured by: Liebel-Flarshelm Company, LLC., Raleigh, NC 27616; NDC 0019-1323-00.

D-0137-2020

September 13, 2019

Class II

Product summary

Firm
GUERBET LLC
Event
Event 83798
Status
Terminated
Classification
Class II
Quantity
3860 syringes
Official record key
drug-enforcement:D-0137-2020

Official wording

Reason: Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.

Code information: Lots: L141C, L162A Exp. 06/2021; L146DS, Exp. 05/2021

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Labeling: Not Elsewhere Classified: RFID formatting error which reads product in Ultraject syringe as expired and will not allow injection of product by the Optivantage injector.